Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Posts 8.6-Percent Rise in Q4 Revenue as Profit Widens 250 Percent

NEW YORK (GenomeWeb News) — Beckman Coulter today said fourth-quarter revenues increased 8.6 percent as R&D spending receded 2.7 percent and profit jumped 250 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $712 million from $655.5 million year over year.
 
Product-related revenue increased 8.1 percent to $104 million while service-related revenue was up 8.7 percent to $608 million.
 
R&D spending decreased slightly to $57.6 million from $59.2 million in the previous fourth quarter.
 
The company said profit increased to $62.3 million from $17.8 million in the year-ago period.
 
The company attributed the increase to smaller operating expenses. Specifically, in the fourth quarter in 2005 the company paid $32.9 million more in restructuring costs, had a $10.7 million “asset impairment” charge, and spent $11.4 million more in selling and administrative costs.
 
BC said it had around $75.2 million in cash and equivalents as of Dec. 31, 2006.
 
The company said it expects 2007 revenue to grow between 7 percent and 9 percent over 2006.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.